link
Bookmarks
Metals and Minerals
Nathan D. Cecava, MD
To access 4,300 diagnoses written by the world's leading experts in radiology.Try it free - 15 days
0
3
24
0

KEY FACTS

  • Imaging

    Selected References

    1. Cook FJ et al: Non-endemic skeletal fluorosis: causes and associated secondary hyperparathyroidism (case report and literature review). Bone. 145:115839, 2021
    2. Kalahasthi R et al: Association between musculoskeletal pain and bone turnover markers in long-term Pb-exposed workers. J Res Health Sci. 21(3):e00522, 2021
    3. Sellami M et al: Skeletal fluorosis: don't miss the diagnosis! Skeletal Radiol. 49(3):345-57, 2020
    4. Apte A et al: Lead toxicity from retained bullet fragments: a systematic review and meta-analysis. J Trauma Acute Care Surg. 87(3):707-16, 2019
    5. Igbokwe IO et al: Aluminium toxicosis: a review of toxic actions and effects. Interdiscip Toxicol. 12(2):45-70, 2019
    6. Klein GL: Aluminum toxicity to bone: a multisystem effect? Osteoporos Sarcopenia. 5(1):2-5, 2019
    7. Nguyen KL et al: Multicenter safety and practice for off-label diagnostic use of ferumoxytol in MRI. Radiology. 293(3):554-64, 2019
    8. Peicher K et al: Skeletal fluorosis due to fluorocarbon inhalation from an air dust cleaner. Calcif Tissue Int. 101(5):545-8, 2017
    9. Tucci JR et al: Skeletal fluorosis due to inhalation abuse of a difluoroethane-containing computer cleaner. J Bone Miner Res. 32(1):188-95, 2017
    10. Baranowska-Bosiacka I et al: Environmental lead (Pb) exposure versus fatty acid content in blood and milk of the mother and in the blood of newborn children. Biol Trace Elem Res. 170(2):279-87, 2016
    11. Bashir MR et al: Emerging applications for ferumoxytol as a contrast agent in MRI. J Magn Reson Imaging. 41(4):884-98, 2015
    12. Newman N et al: Investigation of childhood lead poisoning from parental take-home exposure from an electronic scrap recycling facility - Ohio, 2012. MMWR Morb Mortal Wkly Rep. 64(27):743-5, 2015
    13. Wani AL et al: Lead toxicity: a review. Interdiscip Toxicol. 8(2):55-64, 2015
    14. Cohen E et al: Rapid-onset diffuse skeletal fluorosis from inhalant abuse: a case report. JBJS Case Connect. 4(4):e108, 2014
    15. Rostoker G et al: Magnetic resonance imaging repercussions of intravenous iron products used for iron-deficiency anemia and dialysis-associated anemia. J Comput Assist Tomogr. 38(6):843-4, 2014
    16. Storey P et al: Bone marrow uptake of ferumoxytol: a preliminary study in healthy human subjects. J Magn Reson Imaging. 39(6):1401-10, 2014
    17. Schieda N: Parenteral ferumoxytol interaction with magnetic resonance imaging: a case report, review of the literature and advisory warning. Insights Imaging. 4(4):509-12, 2013
    18. Sidhu HS et al: Imaging features of therapeutic drug-induced musculoskeletal abnormalities. Radiographics. 32(1):105-27, 2012
    19. Rosin A: The long-term consequences of exposure to lead. Isr Med Assoc J. 11(11):689-94, 2009
    20. Sanders T et al: Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health. 24(1):15-45, 2009
    21. Lawson J: Drug-induced metabolic bone disorders. Semin Musculoskelet Radiol. 6(4):285-97, 2002
    22. Murphey MD et al: Musculoskeletal manifestations of chronic renal insufficiency. Radiographics. 13(2):357-79, 1993
    Related Anatomy
    Loading...
    Related Differential Diagnoses
    Loading...
    References
    Tables

    Tables

    KEY FACTS

    • Imaging

      Selected References

      1. Cook FJ et al: Non-endemic skeletal fluorosis: causes and associated secondary hyperparathyroidism (case report and literature review). Bone. 145:115839, 2021
      2. Kalahasthi R et al: Association between musculoskeletal pain and bone turnover markers in long-term Pb-exposed workers. J Res Health Sci. 21(3):e00522, 2021
      3. Sellami M et al: Skeletal fluorosis: don't miss the diagnosis! Skeletal Radiol. 49(3):345-57, 2020
      4. Apte A et al: Lead toxicity from retained bullet fragments: a systematic review and meta-analysis. J Trauma Acute Care Surg. 87(3):707-16, 2019
      5. Igbokwe IO et al: Aluminium toxicosis: a review of toxic actions and effects. Interdiscip Toxicol. 12(2):45-70, 2019
      6. Klein GL: Aluminum toxicity to bone: a multisystem effect? Osteoporos Sarcopenia. 5(1):2-5, 2019
      7. Nguyen KL et al: Multicenter safety and practice for off-label diagnostic use of ferumoxytol in MRI. Radiology. 293(3):554-64, 2019
      8. Peicher K et al: Skeletal fluorosis due to fluorocarbon inhalation from an air dust cleaner. Calcif Tissue Int. 101(5):545-8, 2017
      9. Tucci JR et al: Skeletal fluorosis due to inhalation abuse of a difluoroethane-containing computer cleaner. J Bone Miner Res. 32(1):188-95, 2017
      10. Baranowska-Bosiacka I et al: Environmental lead (Pb) exposure versus fatty acid content in blood and milk of the mother and in the blood of newborn children. Biol Trace Elem Res. 170(2):279-87, 2016
      11. Bashir MR et al: Emerging applications for ferumoxytol as a contrast agent in MRI. J Magn Reson Imaging. 41(4):884-98, 2015
      12. Newman N et al: Investigation of childhood lead poisoning from parental take-home exposure from an electronic scrap recycling facility - Ohio, 2012. MMWR Morb Mortal Wkly Rep. 64(27):743-5, 2015
      13. Wani AL et al: Lead toxicity: a review. Interdiscip Toxicol. 8(2):55-64, 2015
      14. Cohen E et al: Rapid-onset diffuse skeletal fluorosis from inhalant abuse: a case report. JBJS Case Connect. 4(4):e108, 2014
      15. Rostoker G et al: Magnetic resonance imaging repercussions of intravenous iron products used for iron-deficiency anemia and dialysis-associated anemia. J Comput Assist Tomogr. 38(6):843-4, 2014
      16. Storey P et al: Bone marrow uptake of ferumoxytol: a preliminary study in healthy human subjects. J Magn Reson Imaging. 39(6):1401-10, 2014
      17. Schieda N: Parenteral ferumoxytol interaction with magnetic resonance imaging: a case report, review of the literature and advisory warning. Insights Imaging. 4(4):509-12, 2013
      18. Sidhu HS et al: Imaging features of therapeutic drug-induced musculoskeletal abnormalities. Radiographics. 32(1):105-27, 2012
      19. Rosin A: The long-term consequences of exposure to lead. Isr Med Assoc J. 11(11):689-94, 2009
      20. Sanders T et al: Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health. 24(1):15-45, 2009
      21. Lawson J: Drug-induced metabolic bone disorders. Semin Musculoskelet Radiol. 6(4):285-97, 2002
      22. Murphey MD et al: Musculoskeletal manifestations of chronic renal insufficiency. Radiographics. 13(2):357-79, 1993